Coriell’s bioinformatics scientists are an essential part of our team. They play a critical role in our cancer research, help make the samples in our care more accessible, and collaborate with scientists all over the world. Gennaro Calendo is the Associate Director of Bioinformatics at Coriell and answered a few questions about his team and their work.
read moreDr. Nora Engel's research focuses on the disparities between the biological sexes in progression and metastasis of melanoma, but better understanding these factors for melanoma can also elucidate how our sex chromosomes may affect our risk for other forms of cancer, as well as other diseases. Here, Dr. Engel answers questions about her work studying melanoma, why those of us with XY sex chromosomes may be more likely to develop the disease than those of us with other arrangements of sex chromosomes, and what most interests her about her work.
read moreApplications are now being accepted for a pair of grants offered by the Epigenetic Therapies SPORE. These $50,000 grants are awarded through its Career Enhancement Program (CEP) and Developmental Research Program (DRP) to scientists interested in developing epigenetic therapies for the treatment of cancer.
read moreHigh molecular weight DNA (HMW DNA) samples derived from fibroblasts and induced pluripotent stem cells are now available from the National Institute of General Medical Sciences’ Human Genetic Cell Repository.
read moreExplore our 2023 Annual Report to discover the remarkable journey of the Coriell Institute for Medical Research over the past year. From the launch of the Camden Cancer Research Center to the celebration of the NIGMS Repository's 50th anniversary, this report highlights our commitment to advancing cancer research and biomedical science as a whole.
read moreToday at Coriell, one team is responsible for a sample’s care from beginning to end—the Biobanking Logistics team. This department manages a complex and wide range of tasks and responsibilities to ensure the samples in our care are received and stored properly, and shipped with care to researchers.
read moreFor those affected by a rare disease, there is an accessible way to contribute to the research effort. The Human Genetic Cell Repository (HGCR), sponsored by the National Institute of General Medical Sciences (NIGMS) and hosted at the Coriell Institute, contains many thousands of cell line and DNA samples derived from tissue donations from affected people, allowing researchers to study these diseases and develop new therapies. The collection of samples representing rare diseases is always growing!
read moreDozens of induced pluripotent stem cell (iPSC) lines were added to the collections in Coriell's care last year. See a full list of new lines here.
read moreThe Epigenetic Therapies SPORE offers $50,000 grants through its Career Enhancement and Developmental Research programs to scientists interested in the research of epigenetic therapies in cancer. For more information, including eligibility and award details, kindly review the Request for Applications.
read moreThis past year was another of growth and impact for the Coriell Institute for Medical Research, as detailed here in our 2022 Annual Report. Key milestones and achievements were accomplished in each pillar of our mission.
read more